How the product works:
- Bivalirudin is a selective direct thrombin inhibitor
- Inhibits both free and clot-bound thrombin
- Reduces risk of thrombotic complications during PCI
Recommended for:
- Patients undergoing percutaneous coronary intervention
- Patients with a history of heparin-induced thrombocytopenia
- In combination therapy with aspirin and/or other antiplatelet agents
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)